Reeses Tabtussin
Product Images NDC 10956-161

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Reeses Tabtussin (NDC 10956-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Reese Pharmaceutical Co, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (Carton)

This is a drug information sheet for Tabtussin, which is used for cough suppression and as an expectorant. The active ingredients in each tablet are Guaifenesin 400mg and Dextromethorphan HBr 20mg. The drug is used for temporary relief of cough due to throat and bronchial irritation caused by common cold, loosening of phlegm and thinning of bronchial secretions to ease mucus, and for making coughs more productive. However, it is important to consult with a doctor before using Tabtussin if you have a chronic cough, fever, rash or persistent headache or are pregnant or breastfeeding, and to notify them if you are taking any prescription drugs or have certain health conditions. It is also important to not exceed the recommended dose limit of 6 caplets a day for adults and children over 12 years of age.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.